Company Filing History:
Years Active: 2025
Title: Adam Duerfeldt: Innovator in Ocular Disease Treatment
Introduction
Adam Duerfeldt is a notable inventor based in Norman, OK (US). He has made significant contributions to the field of medicine, particularly in the treatment of ocular diseases. With a total of 2 patents, Duerfeldt's work focuses on enhancing therapeutic options for conditions involving inflammation and angiogenesis.
Latest Patents
Duerfeldt's latest patents include innovative compounds that act as agonists of peroxisome proliferator-activated receptor alpha (PPARα). These patents detail benzyl derivative compounds that possess PPARα agonistic activity. The methods of use outlined in these patents aim to treat various ocular diseases and conditions, such as retinal inflammation, retinal neovascularization, and diabetic retinopathy. His work is crucial in developing kits and compositions that enhance PPARα activity, providing new avenues for treating diseases associated with inflammation and angiogenesis.
Career Highlights
Adam Duerfeldt is affiliated with the University of Oklahoma, where he continues to advance his research and innovation in the medical field. His dedication to improving treatment options for ocular diseases has positioned him as a key figure in this area of study.
Collaborations
Duerfeldt collaborates with esteemed colleagues, including Xiaozheng Dou and Ziwei Hu. These partnerships enhance the research efforts and contribute to the development of effective treatments for ocular conditions.
Conclusion
Adam Duerfeldt's contributions to the field of ocular disease treatment through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health issues but also paves the way for future research and development in this vital area.